PHAXIAM Therapeutics S.A. Noncurrent Lease Liabilities
PHAXIAM Therapeutics S.A. had Noncurrent Lease Liabilities of EUR 2.56 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes › Leases
ifrs-full:NoncurrentLeaseLiabilities · last filed 2023-09-26
- 2023-06-30: Noncurrent Lease Liabilities 2.56M EUR.
- 2022-12-31: Noncurrent Lease Liabilities 2.68M EUR.
- 2022-06-30: Noncurrent Lease Liabilities 2.98M EUR.
- 2021-12-31: Noncurrent Lease Liabilities 8.16M EUR.
| Period end | Noncurrent Lease Liabilities |
|---|---|
| 2023-06-30 | 2.56M EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 2.68M EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 2.98M EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 8.16M EUR 20-F · filed 2023-03-28 |
| 2021-06-30 | 8.81M EUR 6-K · filed 2021-09-20 |
| 2020-12-31 | 9.20M EUR 20-F · filed 2023-03-28 |
| 2020-06-30 | 10.47M EUR 6-K · filed 2020-09-21 |
| 2019-12-31 | 11.28M EUR 20-F · filed 2022-04-27 |
| 2019-06-30 | 8.10M EUR 6-K · filed 2019-09-26 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-08 |